Compare TYL & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TYL | PEN |
|---|---|---|
| Founded | 1966 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 12.9B |
| IPO Year | 1996 | 2015 |
| Metric | TYL | PEN |
|---|---|---|
| Price | $344.60 | $332.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $474.36 | $357.33 |
| AVG Volume (30 Days) | 431.8K | ★ 509.9K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.01 | ★ 1155.56 |
| EPS | ★ 7.20 | 4.52 |
| Revenue | $493,101,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $9.59 | $14.34 |
| Revenue Next Year | $9.70 | $13.71 |
| P/E Ratio | ★ $46.98 | $73.56 |
| Revenue Growth | ★ 18.35 | 17.50 |
| 52 Week Low | $283.72 | $221.26 |
| 52 Week High | $621.34 | $362.41 |
| Indicator | TYL | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 46.81 |
| Support Level | $341.98 | $326.58 |
| Resistance Level | $365.00 | $338.99 |
| Average True Range (ATR) | 9.98 | 2.25 |
| MACD | 1.25 | 0.40 |
| Stochastic Oscillator | 91.70 | 53.48 |
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.